Next-generation ALK inhibitors are highly active in ALK-positive large B-cell lymphoma. Soumerai JD, Rosenthal AC, Harkins SK, Duffy J, et al. Blood 2022 Jul 8. pii: 485824. doi: 10.1182/blood.2022015443.

Read + Share

Amedeo Smart

Independent Medical Education

Soumerai JD, Rosenthal AC, Harkins SK, Duffy J, et al. Next-generation ALK inhibitors are highly active in ALK-positive large B-cell lymphoma. Blood 2022 Jul 8. pii: 485824. doi: 10.1182/blood.2022015443.
PMID: 35802834